ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 849 filers reported holding ISHARES TR in Q3 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,013,519 | -2.7% | 7,847 | -1.1% | 0.68% | -7.6% |
| Q4 2022 | $1,042,049 | +8.8% | 7,937 | -3.1% | 0.73% | +9.1% |
| Q3 2022 | $958,000 | -4.6% | 8,192 | -4.0% | 0.67% | +1.7% |
| Q2 2022 | $1,004,000 | -12.2% | 8,537 | -2.7% | 0.66% | +5.6% |
| Q1 2022 | $1,144,000 | -15.9% | 8,777 | -1.6% | 0.63% | -13.6% |
| Q4 2021 | $1,361,000 | -7.1% | 8,917 | -1.6% | 0.73% | -13.8% |
| Q3 2021 | $1,465,000 | +19.8% | 9,059 | +0.3% | 0.84% | -17.5% |
| Q3 2020 | $1,223,000 | +7.8% | 9,029 | +8.7% | 1.02% | -0.3% |
| Q2 2020 | $1,135,000 | +22.7% | 8,304 | -3.3% | 1.02% | -3.6% |
| Q1 2020 | $925,000 | -8.7% | 8,589 | +2.2% | 1.06% | +18.9% |
| Q4 2019 | $1,013,000 | +16.3% | 8,404 | -4.0% | 0.89% | +8.6% |
| Q3 2019 | $871,000 | -10.6% | 8,754 | -2.0% | 0.82% | -11.7% |
| Q2 2019 | $974,000 | -10.6% | 8,929 | -3.0% | 0.93% | -17.1% |
| Q2 2018 | $1,090,000 | +15.2% | 9,209 | +3.9% | 1.12% | -10.1% |
| Q1 2018 | $946,000 | – | 8,867 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |